Does Zyrtec Show Up on a Drug Test? Employer Guide

Quick answer: No. Zyrtec (cetirizine) is not a target of the standard 5-panel or DOT drug test, and routine urine screens do not look for it. Cross-reactivity from over-the-counter antihistamines is rare, and any presumptive positive should be confirmed by laboratory testing (GC-MS or LC-MS/MS) and medical review.

• Cetirizine is not one of the five drug classes in the federal panel, so it does not produce a positive on its own.
• Immunoassay screens can occasionally cross-react with unrelated compounds, which is why a screen is only presumptive.
• Confirmation testing and Medical Review Officer (MRO) review, not the screening device, decide a final result.

What a standard drug test actually detects

Zyrtec does not show up as a positive on a standard workplace drug test. The federal-style panel targets five drug classes: marijuana metabolite (THCA), cocaine metabolite (benzoylecgonine), amphetamines, opiates, and phencyclidine (PCP). Cetirizine is a second-generation antihistamine and is not in any of those classes. The HHS Mandatory Guidelines, published through SAMHSA, define the panel and cutoffs for federally regulated testing, and DOT testing under 49 CFR Part 40 follows them.

Federal urine cutoff levels (HHS Mandatory Guidelines)

Cutoffs are expressed in ng/mL. The initial test is a screen, and the confirmatory test is run by a laboratory with a more specific method.

Source: SAMHSA, HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (urine). Non-regulated employers often use the same or similar cutoffs, but they can differ, so check the cutoffs printed on the specific device you buy.

Can Zyrtec cause a false positive?

It is unlikely. Immunoassay screens use antibodies that bind a drug or its metabolite, and structurally similar compounds can sometimes bind too. Cross-reactivity has been documented for some other antihistamines, such as diphenhydramine, on certain assays. Documentation for cetirizine is much thinner, and results vary by manufacturer and lot. Treat any claim of a guaranteed false positive or guaranteed clean result with caution.

Because screens are presumptive, the safeguard is the process: send non-negative specimens for confirmation, and have an MRO review a confirmed result against the donor's prescriptions and medications. Confirmation methods such as GC-MS and LC-MS/MS identify the specific molecule, so a look-alike compound like an antihistamine does not carry through.

Related point: hydroxyzine

Cetirizine is the active metabolite of hydroxyzine, a prescription antihistamine. Donors may disclose either one. Neither is a federally tested drug, so disclosure matters mainly if a screen result is unexpected and the MRO needs a medication history.

What this means for clinics, employers and courts

Your risk is not the allergy medication. It is a poor process around a presumptive result. Build your program so that a questionable screen never becomes an adverse action on its own.

Program checklist

• Confirm the panel and cutoffs on every device match your written policy, in ng/mL.
• Verify the FDA clearance and CLIA-waived status of each point-of-care product before you deploy it.
• Read results within the time window in the instructions, and do not re-read after it expires.
• Treat every non-negative screen as presumptive until lab confirmation.
• Send presumptive positives to a certified laboratory for GC-MS or LC-MS/MS confirmation.
• Route confirmed results to an MRO who can review legitimate medications.
• Document chain of custody, lot numbers and expiration dates for each collection.
• Give donors a chance to disclose medications confidentially.

How to read an instant test result

1. Check the device expiration date and that the specimen temperature is in range, if the cup has a strip.
2. Wait the stated read time, usually about five minutes.
3. Confirm the control line appears. No control line means an invalid test, so repeat with a new device.
4. For each drug line, two lines (even faint) indicate negative, while a missing line indicates a presumptive positive at that cutoff.
5. Record the result and forward any presumptive positive for confirmation.

Choosing supplies for allergy-medication-proof workflows

Because a screen is only a first step, the right supplies make the follow-up easy. Integrated drug test cups let you collect, check temperature and read results in one device, with a specimen ready to send for lab confirmation. If you need help matching panels, cutoffs and confirmation services to your policy, you can contact American Screening Corp. We supply clinics, hospitals, treatment centers, courts and probation offices, labs, staffing firms and employers from Shreveport, Louisiana.

Frequently asked questions

Does Zyrtec show up on a standard 5-panel drug test?

No. Cetirizine is not a target of the five drug classes on a standard panel: marijuana, cocaine, amphetamines, opiates and PCP.

Can Zyrtec cause a false positive on a urine drug screen?

It is rare and poorly documented for cetirizine. Some antihistamines have shown cross-reactivity on certain immunoassays, so a presumptive positive should always be confirmed by laboratory testing.

Do donors need to disclose Zyrtec before a DOT drug test?

Donors are not generally asked to list medications at collection. If a confirmed result is reported, the MRO interviews the donor about medications and decides whether there is a legitimate explanation.

What should we do with a presumptive positive result?

Do not take adverse action on the screen alone. Send the specimen for GC-MS or LC-MS/MS confirmation, then have an MRO review any confirmed result before a final decision.

Sources

• SAMHSA: Workplace Drug Testing and HHS Mandatory Guidelines
• U.S. DOT ODAPC: 49 CFR Part 40
• FDA: Drugs of Abuse Tests

For related screening needs, our sister division Reveal Background handles employment background checks.

This article is general information, not legal or medical advice.